Different mechanisms have been proposed to explain the bone impairment in PWS subjects, including the multiple endocrine abnormalities that requires treatment with recombinant growth hormone (rhGH) in childhood, and later sex steroid replacement therapy. The gene discussed is GH1; the disease is Prader-Willi syndrome.